Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

New Solvent Ink Meets Regulatory Requirements

HP 2600 ink from HP Printing Specialty Solutions has been formulated to meet existing and future regulatory requirements.

HP 2600 is aimed at solving a variety of consumer and brand packaging and processing challenges as well as addressing a broader industry push for more sustainable solutions.
HP 2600 is aimed at solving a variety of consumer and brand packaging and processing challenges as well as addressing a broader industry push for more sustainable solutions.

On display at HP Inc.’s booth at PACK EXPO Las Vegas was the company’s newest solvent ink for thermal inkjet printing, HP 2600. According to the company, HP 2600 is aimed at solving a variety of consumer and brand packaging and processing challenges as well as addressing a broader industry push for more sustainable solutions. 

“Manufacturers today need the confidence that printed product identification is safe for intended use and will remain legible throughout the manufacturing and distribution process, especially on a wide range of packaging,” explained the company. “HP 2600 has demonstrated its ability to show excellent durability results on untreated polyethylene. This latest product introduction also provides outstanding durability on PVC, in addition to providing good durability on various other types of films such as BOPP.”

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?